Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Q-122 as a novel non-hormonal oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blinded, placebo-controlled trial

Vrselja A, Latifi A, Baber RJ, Stuckey BGA, Walker MG, Stearns V, Hickey M, Davis SR

(2022), Lancet, 400(10364), 1704-11

DOI: 10.1016/S0140-6736(22)01977-8

Treating menopause - MHT and beyond

Davis SR, Baber R

(2022), NAT REV ENDOCRINOL, 18(8), 490-502

DOI: 10.1038/s41574-022-00685-4

Functional hypothalamic amenorrhoea, a diagnosis of exclusion

Ng E, Sztal-Mazer S, Davis SR

(2022), MED J AUSTRALIA, 216(2), 73-6

DOI: 10.5694/mja2.51376

Re: A system to detect unrecognised diabetes in a tertiary hospital

Ng E, Scholes G, Bach LA, Topliss DJ, Schneider HG, Sztal-Mazer S

(2022), Diabetic Med, 39(8), e14841

DOI: 10.1111/dme.14841

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Burman P, Trouillas J, Losa M, McCormack,A, Petersenn S, Popovic V, Theodoropoulou M, Raverot G, Dekkers OM for the ESE survey collaborators

(2022), Eur J Endocrinol, 187(4), 593-605

DOI: 10.1530/EJE-22-0440

Adrenal gland haemorrhages following motor vehicle accident with resultant adrenal insufficiency

Szwarcbard N, Davis A, Bach LA, Hackman K

(2022), Endocrinology, diabetes & metabolism case reports, 2022(1), 21-0208

DOI: 10.1530/EDM-21-0208

Capillary ketone concentrations at the time of colonoscopy: A cross-sectional study with implications for SGLT2 inhibitor-treated type 2 diabetes (response to correspondence)

Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA

(2022), Diabetes Care, 45(1), e17-18

DOI: 10.2337/dc21-0256

Diabetic ketoacidosis: a canary in the mine for mental health disorders?

Hamblin PS, Abdul-Wahab AL, Xu SFB, Steele CE, Vogrin S

(2022), Intern Med J, 52(6), 1002-8

DOI: 10.1111/imj.15214

Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use

Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA

(2022), Clin Endocrinol, 96(4), 549-57

DOI: 10.1111/cen.14621

Medical and Surgical Treatment of Thyroid Eye Disease

Hall AJ, Topliss DJ

(2022), Intern Med J, 52(1), 14-20

DOI: 10.1111/imj.15067

Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, Ambler GR, Cameron FJ, McAuley SA, Keech AC, Jenkins A, Davis EA, O'Neal DN, Jones TW; Australian Juvenile Diabetes Research Fund Closed-Loop Research group

(2021), JAMA Pediatr, 175(12), 1227-35

DOI: 10.1001/jamapediatrics.2021.3965

Sepsis and adrenal insufficiency: a potentially lethal combination

Hamblin PS, Yeap BB, Torpy DJ

(2021), MED J AUSTRALIA, 214(7), 334-334e.1

DOI: 10.5694/mja2.50993

Determinants of Cardiovascular Risk in 7000 Youth With Type 1 Diabetes in the Australasian Diabetes Data Network

Couper JJ, Jones TW, Chee M, Barrett HL, Bergman P, Cameron F, Craig ME, Colman P, Davis EE, Donaghue KC, Fegan PG, Hamblin PS, Holmes-Walker DJ, Jefferies C, Johnson S, Mok MT, King BR, Sinnott R, Ward G, Wheeler BJ, Zimmermann A, Earnest A

(2021), J CLIN ENDOCR METAB, 106(1), 133-42

DOI: 10.1210/clinem/dgaa727

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators

(2021), NEW ENGL J MED, 385(24), 2252-63

DOI: 10.1056/NEJMoa2110956

Psychosis induced by hypothyroidism mistaken for brief reactive psychosis

Gillies RD, Moseley G, Ng E, Bach L, Zhang J

(2021), AUST NZ J PSYCHIAT, 55(10), 1022

DOI: 10.1177/0004867421998764

Sodium glucose co-transporter-2 inhibitor-induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners

Yap SD, Hamblin PS, Bach L, Ekinci E, Wong R

(2021), Aust Dent J, 66(4), 444-7

DOI: 10.1111/adj.12872

Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes

Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA

(2021), Diabetes Care, 44(6), e124-6

DOI: 10.2337/dc21-0256

Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways

Huang KW, Wang IH, Fu P, Krum H, Bach LA, Wang BH

(2021), International journal of cardiology. Heart & vasculature, 36, 100852

DOI: 10.1016/j.ijcha.2021.100852

Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections

McAuley SA, Vogrin S, Lee MH, Paldus B, Trawley S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Ward GM, Jones TW, O'Neal DN; Australian JDRF Closed-Loop Research Group

(2021), DIABETES TECHNOL THE, 23(6), 460-6

DOI: 10.1089/dia.2020.0589

Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision

Lu JC, Vogrin S, McAuley SA, Lee MH, Paldus B, Bach LA, Burt MG, Clarke PM, Cohen ND, Colman PG, de Bock MI, Jane Holmes-Walker D, Jenkins AJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Roem K, Sims C, Stranks SN, Trawley S, Ward GM, Sundararajan V, Jones TW, O'Neal DN; Australian JDRF Closed-Loop Research Group

(2021), DIABETES RES CLIN PR, 179, 109000

DOI: 10.1016/j.diabres.2021.109000

1 2 3 4 5